Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P29
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -10.83% |
| 2023 | 4.26% |
| 2022 | 5.86% |
| 2021 | -2.50% |
| 2020 | 14.46% |
| 2019 | 11.74% |
| 2018 | 78.36% |
| 2017 | -41.06% |
| 2016 | -38.80% |
| 2015 | 289.46% |